Orzel Spolka Akcyjna Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Orzel Spolka Akcyjna.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Chemicals earnings growth | 21.9% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Orzel Spolka Akcyjna (WSE:ORL) Has More To Do To Multiply In Value Going Forward
Jul 24
Calculating The Fair Value Of Orzel Spolka Akcyjna (WSE:ORL)
Dec 22If EPS Growth Is Important To You, Orzel Spolka Akcyjna (WSE:ORL) Presents An Opportunity
Sep 29Should You Be Adding Orzel Spolka Akcyjna (WSE:ORL) To Your Watchlist Today?
May 13If You Like EPS Growth Then Check Out Orzel Spolka Akcyjna (WSE:ORL) Before It's Too Late
Jan 25Estimating The Fair Value Of Orzel Spolka Akcyjna (WSE:ORL)
Aug 03A Look At The Fair Value Of Orzel Spolka Akcyjna (WSE:ORL)
Mar 12Orzel Spolka Akcyjna (WSE:ORL) Has A Somewhat Strained Balance Sheet
Dec 11
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Orzel Spolka Akcyjna has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 9/30/2024 | 18 | 2 | -18 | 3 | N/A |
| 6/30/2024 | 17 | 2 | -18 | 4 | N/A |
| 3/31/2024 | 17 | 2 | -11 | 3 | N/A |
| 12/31/2023 | 17 | 2 | -9 | 4 | N/A |
| 9/30/2023 | 18 | 3 | -4 | 5 | N/A |
| 6/30/2023 | 16 | 2 | 0 | 3 | N/A |
| 3/31/2023 | 15 | 2 | 3 | 3 | N/A |
| 12/31/2022 | 15 | 3 | 3 | 3 | N/A |
| 9/30/2022 | 14 | 2 | 2 | 3 | N/A |
| 6/30/2022 | 14 | 2 | 3 | 4 | N/A |
| 3/31/2022 | 14 | 3 | 2 | 4 | N/A |
| 12/31/2021 | 13 | 3 | 2 | 4 | N/A |
| 9/30/2021 | 12 | 2 | 1 | 3 | N/A |
| 6/30/2021 | 12 | 2 | 1 | 2 | N/A |
| 3/31/2021 | 12 | 1 | 2 | 3 | N/A |
| 12/31/2020 | 11 | 1 | 2 | 2 | N/A |
| 9/30/2020 | 11 | 1 | 2 | 3 | N/A |
| 6/30/2020 | 11 | 2 | 2 | 3 | N/A |
| 3/31/2020 | 11 | 2 | 3 | 3 | N/A |
| 12/31/2019 | 12 | 2 | 2 | 3 | N/A |
| 9/30/2019 | 11 | 2 | 2 | 2 | N/A |
| 6/30/2019 | 11 | 1 | 2 | 2 | N/A |
| 3/31/2019 | 10 | 1 | 1 | 1 | N/A |
| 12/31/2018 | 10 | 1 | 2 | 2 | N/A |
| 9/30/2018 | 11 | 0 | 1 | 2 | N/A |
| 6/30/2018 | 10 | 0 | N/A | 1 | N/A |
| 3/31/2018 | 9 | -1 | N/A | 1 | N/A |
| 12/31/2017 | 9 | -1 | N/A | 0 | N/A |
| 9/30/2017 | 8 | -2 | N/A | 0 | N/A |
| 6/30/2017 | 8 | -2 | N/A | 0 | N/A |
| 3/31/2017 | 7 | -2 | N/A | 0 | N/A |
| 12/31/2016 | 6 | -1 | N/A | 0 | N/A |
| 9/30/2016 | 6 | -2 | N/A | 0 | N/A |
| 6/30/2016 | 6 | -1 | N/A | 1 | N/A |
| 3/31/2016 | 6 | -2 | N/A | 1 | N/A |
| 12/31/2015 | 6 | -2 | N/A | 1 | N/A |
| 9/30/2015 | 6 | -3 | N/A | 3 | N/A |
| 6/30/2015 | 6 | -3 | N/A | 2 | N/A |
| 3/31/2015 | 6 | -4 | N/A | 3 | N/A |
| 12/31/2014 | 7 | -5 | N/A | 2 | N/A |
| 9/30/2014 | 17 | -3 | N/A | 0 | N/A |
| 6/30/2014 | 23 | -4 | N/A | 1 | N/A |
| 3/31/2014 | 31 | -3 | N/A | 3 | N/A |
| 12/31/2013 | 34 | -4 | N/A | 1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if ORL's forecast earnings growth is above the savings rate (4.1%).
Earnings vs Market: Insufficient data to determine if ORL's earnings are forecast to grow faster than the Polish market
High Growth Earnings: Insufficient data to determine if ORL's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if ORL's revenue is forecast to grow faster than the Polish market.
High Growth Revenue: Insufficient data to determine if ORL's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ORL's Return on Equity is forecast to be high in 3 years time